+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Sterol uptake and sterol biosynthesis act coordinately to mediate antifungal resistance in Candida glabrata under azole and hypoxic stress



Sterol uptake and sterol biosynthesis act coordinately to mediate antifungal resistance in Candida glabrata under azole and hypoxic stress



Molecular Medicine Reports 17(5): 6585-6597



Pathogenic fungi, including Candida glabrata, develop strategies to grow and survive both in vitro and in vivo under azole stress. However, the mechanisms by which yeast cells counteract the inhibitory effects of azoles are not completely understood. In the current study, it was demonstrated that the expression of the ergosterol biosynthetic genes ERG2, ERG3, ERG4, ERG10, and ERG11 was significantly upregulated in C. glabrata following fluconazole treatment. Inhibiting ergosterol biosynthesis using fluconazole also increased the expression of the sterol influx transporter AUS1 and the sterol metabolism regulators SUT1 and UPC2 in fungal cells. The microarray study quantified 35 genes with elevated mRNA levels, including AUS1, TIR3, UPC2, and 8 ERG genes, in a C. glabrata mutant strain lacking ERG1, indicating that sterol importing activity is increased to compensate for defective sterol biosynthesis in cells. Bioinformatic analyses further revealed that those differentially expressed genes were involved in multiple cellular processes and biological functions, such as sterol biosynthesis, lipid localization, and sterol transport. Finally, to assess whether sterol uptake affects yeast susceptibility to azoles, we generated a C. glabrata aus1∆ mutant strain. It was shown that loss of Aus1p in C. glabrata sensitized the pathogen to azoles and enhanced the efficacy of drug exposure under low oxygen tension. In contrast, the presence of exogenous cholesterol or ergosterol in medium rendered the C. glabrata AUS1 wild‑type strain highly resistant to fluconazole and voriconazole, suggesting that the sterol importing mechanism is augmented when ergosterol biosynthesis is suppressed in the cell, thus allowing C. glabrata to survive under azole pressure. On the basis of these results, it was concluded that sterol uptake and sterol biosynthesis may act coordinately and collaboratively to sustain growth and to mediate antifungal resistance in C. glabrata through dynamic gene expression in response to azole stress and environmental challenges.

(PDF emailed within 0-6 h: $19.90)

Accession: 065534500

Download citation: RISBibTeXText

PMID: 29532896

DOI: 10.3892/mmr.2018.8716


Related references

Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis. Antimicrobial Agents and ChemoTherapy 59(10): 5942-5950, 2016

Sterol uptake in Candida glabrata: rescue of sterol auxotrophic strains. Diagnostic Microbiology and Infectious Disease 52(4): 285-293, 2005

A Novel Sterol-Signaling Pathway Governs Azole Antifungal Drug Resistance and Hypoxic Gene Repression in Saccharomyces cerevisiae. Genetics 208(3): 1037-1055, 2017

Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. Journal of Biological Chemistry 292(16): 6728-6743, 2017

Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans. Diagnostic Microbiology and Infectious Disease 13(1): 31-35, 1990

Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans. Biochemical Journal 266(2): 475-480, 1990

Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B. Antimicrobial Agents and ChemoTherapy 56(8): 4223-4232, 2013

5-Fluorocytosine antagonizes the action of sterol biosynthesis inhibitors in Candida glabrata. Journal of Antimicrobial ChemoTherapy 43(6): 767-775, 1999

Role of sterol Delta 5(6) desaturase in azole antifungal mode of action and resistance. Pesticide Science 46(3): 294-298, 1996

The mannoprotein TIR3 (CAGL0C03872g) is required for sterol uptake in Candida glabrata. Biochimica et Biophysica Acta 1851(2): 141-151, 2015

Aspergillus fumigatus C-5 sterol desaturases Erg3A and Erg3B: role in sterol biosynthesis and antifungal drug susceptibility. Antimicrobial Agents and ChemoTherapy 50(2): 453-460, 2006

Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrobial Agents and ChemoTherapy 49(2): 668-679, 2005

UPC2A is required for high-level azole antifungal resistance in Candida glabrata. Antimicrobial Agents and ChemoTherapy 58(8): 4543-4554, 2015

The clinical significance of cross-resistance between azole antifungal agents in Candida glabrata. 2007

Clinical significance of azole antifungal drug cross-resistance in Candida glabrata. Journal of Clinical Microbiology 44(5): 1740-1743, 2006